Event Overview

Why the Medical Affairs Essentials Summer School?

Medical affairs and MSL executives are increasingly being expected to improve their capabilities, in line with the medical affairs department’s increasingly central role in the Pharmaceutical or MedTech organization. Medical affairs and liaisons need to deepen their ability to communicate and engage with KOLs, external experts and other stakeholders and this increasingly requires more powerful “soft skills” such as communication and persuasion. Furthermore, in terms of written communication, medical writing skills are as important as ever and working closely with KOLs and investigators to produce interesting publications that appeal to a broad audience is key. Medical affairs professionals also need to improve their technical expertise in areas like late-phase trial design and the implementation of real-world, observational studies, to maximize the opportunity to capture essential evidence of product value.

The Medical Affairs Essentials Summer School is a unique chance for professionals in this increasingly important function to both deepen and broaden their skills and abilities in the areas of KOL communication, stakeholder engagement, late-phase study development and implementation, as well as to demonstrate the value of a product in clinical, but also economic terms.

The 2 day course will be run as a series of 4 x half-day workshops, led by expert consultants and experienced industry representatives. The concept is to give medical affairs team members a condensed set of training to bring them up to the highest standard or as a refresher for those looking to implement best practices in medical affairs. All training will be focused on real-world scenarios and challenges specific to their roles, from experienced practitioners. All workshops will be in 50% didactic/presentation-style and 50% interactive sessions (small groups syndicates & real-world scenarios).

Speakers List

Workshop Leaders

Jessica Ingram

Managing Director
OPEN Health Medical Communications

Oliver Leatham

Vice President, Head of Value and Access

Principal, Real-World & Late Phase
Syneos Health

Luke Rogers

CEO & co-Founder                             
NextLevel Life Sciences                      

Geoff Cable

CEO & co-Founder                            
NextLevel Life Sciences  

Event Structure

Photo Gallery

Event Overview

Enabling Medical Teams to Critically Appraise Data

Day 1 - Workshop 1 - AM - 17th June, 2020

Market Access & Health Economics for Medical Affairs

Day 1 - Workshop 2 - PM - 17th June, 2020

Real-World and Late-Phase Studies in Practice

Day 2 - Workshop 3 - AM - 18th June, 2020

Soft Skills for Persuasion & Value Communication (Internal & External)

Day 2 - Workshop 4 - PM - 18th June, 2020

Medical Affairs, Medical Directors, Medical Science Liaison and field medical, Medical Advisors, Health Outcomes Liaison, KOL and External Stakeholder Engagement, Medical Communications, Publication & CME Executives.

Event Partners

Related Videos


Biopharmaceutical Acceleration Model for product development and commercialization

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Meeting the needs of health system stakeholders demanding both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Case study: The benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs

Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK


Leveraging online discussion platforms for optimal KOL & Physician engagement

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global KOL engagement 
  • Which solutions can enable Pharma & MedTech to better engage & generate valuable insights from KOLs & External Experts 
  • Improving KOL engagement outcomes while maintaining regulatory compliance

Pauline De Mari
Vaccines Innovative Medical Engagement Lead

Andy Bowman
Managing Director

View Agenda or Register